The use of complementary and alternative medicine (CAM) in the United States has increased dramatically in the past 10 years. As with the general population, patients with cancer typically use CAM-based modalities in combination with their conventional cancer treatments. Traditional Chinese medicine (TCM) is one of the most ancient alternative medical systems and is being practiced throughout the world today. TCM has been practiced in China as routine therapy for more than 5000 years and is rapidly gaining popularity in western countries. A significant component of TCM is the use of herbal- and animal-based products, from which some important chemotherapy agents have been derived. Other aspects of TCM modalities include acupuncture and energy-based treatments. As researchers begin to examine the scientific bases of many non-conventional biologically-based therapies in a rigorous and controlled manner, some will be found to have clinical benefit. The proposed planning grant is the first step to develop an international center for evaluation of TCM in cancer. This initial planning phase will allow examination and strengthening of the research infrastructure at Cancer Hospital, Fundan University (CHFU), Shanghai, China, one of the top cancer centers in China and will promote an educational exchange between CHFU and The University of Texas M. D. Anderson Cancer Center (MDACC). We propose to establish a partnership and cross-cultural exchange through which investigators at MDACC and CHFU will collaborate to study TCM in appropriate clinical and laboratory environments. In order to evaluate the strengths and weaknesses of the international collaborative team, we will develop three separate but overlapping areas of research during the period of this planning grant. We will move each area of research forward in parallel to determine how best to develop a fully functional and productive international collaborative team. The three collaborative research programs that will be developed include: evaluating herbal/natural product treatments that target disease outcomes and treatment- and disease-related symptoms; determining the effects of acupuncture on specific clinical symptoms in patients with cancer; and examining the biobehavioral effects of qigong and other mind/body-based interventions in patients with cancer. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21CA108084-02
Application #
6804597
Study Section
Special Emphasis Panel (ZAT1-K (10))
Program Officer
Xi, Dan
Project Start
2003-09-30
Project End
2006-08-31
Budget Start
2004-09-10
Budget End
2006-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$137,750
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Schools of Medicine
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
You, Jin; Lu, Qian; Zvolensky, Michael J et al. (2018) Anxiety- and Health-Related Quality of Life Among Patients With Breast Cancer: A Cross-Cultural Comparison of China and the United States. J Glob Oncol :1-9
Milbury, Kathrin; Kavanagh, April; Meng, Zhiqiang et al. (2017) Depressive symptoms and positive affect in Chinese and United States breast cancer survivors: a cross-cultural comparison. Support Care Cancer 25:2103-2109
Lu, Qian; You, Jin; Kavanagh, April et al. (2016) Differences in quality of life between American and Chinese breast cancer survivors. Support Care Cancer 24:3775-82
Chen, Zhen; Meng, Zhiqiang; Milbury, Kathrin et al. (2013) Qigong improves quality of life in women undergoing radiotherapy for breast cancer: results of a randomized controlled trial. Cancer 119:1690-8
Ouyang, Huaqiang; Wang, Peng; Meng, Zhiqiang et al. (2011) Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine. Pancreas 40:120-5
Meng, Zhi-Qiang; Garcia, M Kay; Chiang, Joseph S et al. (2010) Electro-acupuncture to prevent prolonged postoperative ileus: a randomized clinical trial. World J Gastroenterol 16:104-11
Meng, Zhiqiang; Yang, Peiying; Shen, Yehua et al. (2009) Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer 115:5309-18